Historical record - last NADAC effective date: 11/18/2015
Product Information
ADVIL 200 MG LIQUI-GEL CAPSULE is a brand product labeled by Haleon US Holdings LLC, priced at $0.1421 per EA under NDC 00573016930. Its NADAC has been published 104 times since Nov 28, 2013.
FDA first approved this application on Apr 20, 1995.
The High Outlier badge above means this manufacturer's average price in the ibuprofen market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
200 mg/1
Manufacturer
Haleon US Holdings LLCNDC
00573016930
Classification
Brand
Dosage Form
CAPSULE, LIQUID FILLED
Route
ORAL
Effective Date
11/18/2015
Active Ingredients
IBUPROFENApproval Type
New Drug (NDA)
FDA Application
NDA020402FDA Approved
4/20/1995
On Market Since
4/10/1995
Pharmacological Classes
Price Statistics
The NADAC for ADVIL 200 MG LIQUI-GEL CAPSULE has been published 104 times since Nov 28, 2013, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1421 per EA |
|---|---|
| All-time high | $0.1514 (Oct 15, 2014) |
| All-time low | $0.1421 (Nov 18, 2015) |
| Median price | $0.1477 |
| Average price | $0.1480 |
| Largest weekly change | -4.9% (Nov 18, 2015) |
| Weeks tracked | 104 |
| Tracking since | Nov 28, 2013 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
N/A
All
-0.8%
Last surveyed Nov 18, 2015 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the ibuprofen market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Haleon US Holdings LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
ibuprofen market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Nonsteroidal Anti-inflammatory Drug class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of ADVIL 200 MG LIQUI-GEL CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for ADVIL 200 MG LIQUI-GEL CAPSULE, manufactured by Haleon US Holdings LLC, is $0.1421 per EA (NDC 00573016930), effective Nov 18, 2015.
How has the price of ADVIL 200 MG LIQUI-GEL CAPSULE changed over time?
Over the history we have for it, the NADAC for ADVIL 200 MG LIQUI-GEL CAPSULE has held within roughly two percent of its current level. It has been tracked across 104 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for ADVIL 200 MG LIQUI-GEL CAPSULE?
Since Nov 28, 2013, the NADAC for ADVIL 200 MG LIQUI-GEL CAPSULE has ranged from a low of $0.1421 (Nov 18, 2015) to a high of $0.1514 (Oct 15, 2014), with a median of $0.1477 per EA.
Are there cheaper alternatives to ADVIL 200 MG LIQUI-GEL CAPSULE?
No other NADAC-published product currently shares the active ingredient and strength of ADVIL 200 MG LIQUI-GEL CAPSULE in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures ADVIL 200 MG LIQUI-GEL CAPSULE?
ADVIL 200 MG LIQUI-GEL CAPSULE (NDC 00573016930) is labeled by Haleon US Holdings LLC, and CMS classifies it as a brand product.